A new generation of Immunotherapy
With multiple FDA clinical trials underway, Diakonos Research is redefining the potential of cancer immunotherapy. Studied both in the lab and in the clinical setting, Diakonos has developed revolutionary approaches to Cancer Immunotherapy that have the ability to address a variety of cancer types.
Unwavering Commitment to Science
Based in the Houston Medical Center, the sole focus of Diakonos is leveraging the body's natural capability of eliminating cancer. Using your immune system combined with our patented treatments, Diakonos has repeatedly demonstrated the ability to activate an immune attack against cancer.
Years of research at established institutions of academic excellence have led to dozens of peer-reviewed publications, patents, out-licenses, FDA clinical trials, and a wealth of opportunities moving forward.
It’s simple – Where biology leads, we follow.
Unlocking the Potential
of the Immune System
Learn more about our science
Diakonos has discovered three separate immunotherapy protocols that take advantage of the immune system's ability to target and fight cancer.
Multiple clinical trials are underway to further validate these approaches to cancer treatment.
Driven by Innovation
Interested in learning more about the Diakonos science or clinical trials?
Our team looks forward to working with clinicians in either exploring new trials or helping patients participate in one of our existing trials.Contact Us